Updates include novel and revised breakpoints for azithromycin, polymyxins, daptomycin, and cefiderocol.
MelANIE T. MAHONEY, MPH, PHARMD STUDENT
Advertisement
Articles by MelANIE T. MAHONEY, MPH, PHARMD STUDENT
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Initiatives Look to Strengthen Vaccine Policy and Governance in US
2
Infectious Disease Regulatory Watch: June Highlights
3
European Commission Approves Glecaprevir/Pibrentasvir for Hepatitis C
4
Efflux Pump Inhibitor Restores Azithromycin Activity Against Multidrug-Resistant Gram-Negative Pathogens
5